NYSE · Asset Management
IVZ (IVZ) Stock
$29.26
-2.82%
NYSE: IVZ
Financial Services
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Barclays Adjusts Price Target on Invesco to $31 From $26, Maintains Equalweight Rating
MT Newswires · Jul 14, 2026
Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?
Zacks · Jul 14, 2026
PBJ vs. FTXG: How Have These Two Food & Beverage ETFs Stacked Up Against One Another (And the S&P 500?)
Motley Fool · Jul 13, 2026
BMO Capital Adjusts Invesco Price Target to $34 From $31, Maintains Outperform Rating
MT Newswires · Jul 13, 2026
1 ETF That Has Quietly Beaten the S&P 500 for a Decade
Motley Fool · Jul 13, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.60%
Institutions Held97.25%
Institutions Float Held97.84%
Peer Comparison
About IVZ
IVZ is led by CEO Andrew Ryan Schlossberg, employs 7,499 people, headquartered in Atlanta, US, publicly traded since 1995.
IVZ stock trades at $29.26 with a market capitalization of $12.97B. The stock is valued at a price-to-earnings (P/E) ratio of 9.74, price-to-book of 1.32, price-to-sales of 1.96. Over the past 52 weeks the stock has ranged between $14.51 and $30.54, and currently trades 4.2% below its 52-week high. It pays a dividend yielding 2.90%.
On profitability, IVZ generates a return on equity (ROE) of -1.53%, return on capital employed of -5.35%, an operating margin of -9.71%, a net profit margin of -3.69%.